ARIXTRA fondaparinux sodium 10mg/0.8mL solution for injection syringe Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arixtra fondaparinux sodium 10mg/0.8ml solution for injection syringe

aspen pharmacare australia pty ltd - fondaparinux sodium, quantity: 10 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery. arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing abdominal surgery who are at risk of thromboembolic complications. arixtra is indicated for the treatment of acute deep venous thrombosis (dvt) and acute pulmonary embolism (pe

ARIXTRA fondaparinux sodium 7.5mg/0.6mL solution for injection syringe Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arixtra fondaparinux sodium 7.5mg/0.6ml solution for injection syringe

aspen pharmacare australia pty ltd - fondaparinux sodium, quantity: 7.5 mg - injection, solution - excipient ingredients: sodium chloride; water for injections - arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery. arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing abdominal surgery who are at risk of thromboembolic complications. arixtra is indicated for the treatment of acute deep venous thrombosis (dvt) and acute pulmonary embolism (pe

ARIXTRA fondaparinux sodium 5.0mg/0.4mL solution  for injection syringe Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arixtra fondaparinux sodium 5.0mg/0.4ml solution for injection syringe

aspen pharmacare australia pty ltd - fondaparinux sodium, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery. arixtra is indicated for the prevention of venous thromboembolic events (vte) in patients undergoing abdominal surgery who are at risk of thromboembolic complications. arixtra is indicated for the treatment of acute deep venous thrombosis (dvt) and acute pulmonary embolism (pe).

ARIXTRA- fondaparinux sodium injection, solution Spojené státy - angličtina - NLM (National Library of Medicine)

arixtra- fondaparinux sodium injection, solution

physicians total care, inc. - fondaparinux sodium (unii: x0q6n9usoz) (fondaparinux - unii:j177fow5jl) - fondaparinux sodium 5 mg in 0.4 ml - arixtra® is indicated for the prophylaxis of deep vein thrombosis (dvt), which may lead to pulmonary embolism (pe): - in patients undergoing hip fracture surgery, including extended prophylaxis; - in patients undergoing hip replacement surgery; - in patients undergoing knee replacement surgery; - in patients undergoing abdominal surgery who are at risk for thromboembolic complications. arixtra is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with warfarin sodium. arixtra is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital. arixtra is contraindicated in the following conditions: - severe renal impairment (creatinine clearance [crcl] <30 ml/min). [see warnings and precautions (5.2) and use in specific populations (8.6).] - active major bleeding. - bacterial endocarditis. - thrombocytopenia associated with a positive in vitro test for anti-platelet antib

FRAGMIN INJ.-LIQ 2500 IU(ANTI-XA)/ML LIQUID Kanada - angličtina - Health Canada

fragmin inj.-liq 2500 iu(anti-xa)/ml liquid

pharmacia & upjohn inc - dalteparin sodium - liquid - 2500unit - dalteparin sodium 2500unit - heparins

Hepsal or Heparin Sodium 10IU/ml flushing solution for maintenance of patency of intravenous devices Malta - angličtina - Medicines Authority

hepsal or heparin sodium 10iu/ml flushing solution for maintenance of patency of intravenous devices

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - heparin sodium - irrigation solution - heparin sodium 10 iu/ml - antithrombotic agents

FONDAPARINUX SODIUM INJECTION SOLUTION Kanada - angličtina - Health Canada

fondaparinux sodium injection solution

dr reddy's laboratories ltd - fondaparinux sodium - solution - 2.5mg - fondaparinux sodium 2.5mg - direct factor xa inhibitors

FONDAPARINUX SODIUM INJECTION SOLUTION Kanada - angličtina - Health Canada

fondaparinux sodium injection solution

dr reddy's laboratories ltd - fondaparinux sodium - solution - 5mg - fondaparinux sodium 5mg - direct factor xa inhibitors

FONDAPARINUX SODIUM INJECTION SOLUTION Kanada - angličtina - Health Canada

fondaparinux sodium injection solution

dr reddy's laboratories ltd - fondaparinux sodium - solution - 7.5mg - fondaparinux sodium 7.5mg - direct factor xa inhibitors

FONDAPARINUX SODIUM INJECTION SOLUTION Kanada - angličtina - Health Canada

fondaparinux sodium injection solution

dr reddy's laboratories ltd - fondaparinux sodium - solution - 10mg - fondaparinux sodium 10mg - direct factor xa inhibitors